Menú

EPIVAC

Group leader
avatar_investigadors.jpg
Cinta de Diego Cabanes
mcdiego.tgn.ics@gencat.cat
avatar_grups_recerca.png

Publications

Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study

Palà E, Bustamante A, Clúa-Espuny JL, Acosta J, González-Loyola F, Santos SD, Ribas-Segui D, Ballesta-Ors J, Penalba A, Giralt M, Lechuga-Duran I, Gentille-Lorente D, Pedrote A, Muñoz MÁ and Montaner J
PLoS One. 2022 Aug 23; . doi:10.1371/journal.pone.0273571; PMID:35998199

  • Ans: 23/08/2022
  • FI: 3.7
See more:
Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017-2018

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. DE DIEGO-CABANES, E. SATUE-GRACIA, V. TORRAS-VIVES, M. FORCADELL-PERIS, D. RIBAS-SEGUI, A. VILA-ROVIRA and C. RODRIGUEZ-CASADO
Vaccine: X. 2023 Apr 1; . doi:10.1016/j.jvacx.2023.100264; PMID:36798107

  • Ans: 01/04/2023
  • FI:
See more:
Epidemiología de la neumonía neumocócica en adultos mayores de 50 años: estudio de cohortes en Cataluña, 2017-2018.

Ochoa-Gondar O, Torras-Vives V, de Diego-Cabanes C, Satué Gracia E, Forcadell-Peris MJ and Vila-Córcoles Á
ATENCION PRIMARIA. 2023 Jul 1; . doi:10.1016/j.aprim.2023.102631; PMID:37119778

  • Ans: 01/07/2023
  • FI: 1.8
See more:
Evaluating pneumococcal vaccine’s effectiveness against pneumonia among adults over 50 years in Catalonia, 2017-2018

C. CABANES, A. VILA-CORCOLES, E. SATUE-GRACIA, O. OCHOA-GONDAR, A. VILA-ROVIRA and M. FORCADELL-PERIS
EUROPEAN RESPIRATORY JOURNAL. 2022 Sep 4; . doi:10.1183/13993003.congress-2022.258;

  • Ans: 04/09/2022
  • FI: 24.3
See more:
Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study

O. OCHOA-GONDAR, V. TORRAS-VIVES, C. DE DIEGO-CABANES, E. SATUÉ-GRACIA, A. VILA-ROVIRA, M. FORCADELL-PERISA, D. RIBAS-SEGUÍ, C. RODRÍGUEZ-CASADO and A. VILA-CÓRCOLES
BMC Pulmonary Medicine. 2023 Jun 8; . doi:10.1186/s12890-023-02497-2; PMID:37291502

  • Ans: 08/06/2023
  • FI: 2.6
See more: